Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BMEDIC ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   1.2% 1.1% 1.0% 1.0% 1.8% 2.2% 6.9% 6.8%   Credit score (0-100)   84 84 85 84 70 61 11 11   Credit rating   BBB BBB A A BBB BBB BB BB   Credit limit (kDKK)   127.4 135.4 236.3 285.5 2.8 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,275 1,960 2,140 2,466 2,728 3,233 0.0 0.0   EBITDA   1,175 757 846 764 1,324 1,697 0.0 0.0   EBIT   1,157 744 837 757 1,324 1,697 0.0 0.0   Pre-tax profit (PTP)   1,133.2 880.1 959.2 1,348.8 869.6 2,117.8 0.0 0.0   Net earnings   884.1 684.1 748.1 1,052.1 676.7 1,647.2 0.0 0.0   Pre-tax profit without non-rec. items   1,133 880 959 1,349 870 2,118 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   30.2 17.4 8.0 0.3 0.0 0.0 0.0 0.0   Shareholders equity total   2,634 3,210 3,848 4,787 5,349 6,879 799 799   Interest-bearing liabilities   88.2 56.8 49.7 92.7 103 111 0.0 0.0   Balance sheet total (assets)   3,950 4,452 5,354 6,122 6,307 8,207 799 799   Net Debt   -2,757 -3,233 -3,508 -4,326 -4,270 -6,074 -799 -799     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,275 1,960 2,140 2,466 2,728 3,233 0.0 0.0   Gross profit growth   24.9% -13.8% 9.2% 15.2% 10.6% 18.5% -100.0% 0.0%   Employees   2 2 2 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,950 4,452 5,354 6,122 6,307 8,207 799 799   Balance sheet change%   40.7% 12.7% 20.3% 14.3% 3.0% 30.1% -90.3% 0.0%   Added value   1,174.8 757.0 846.3 764.3 1,331.6 1,697.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -35 -26 -19 -15 -1 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   50.9% 38.0% 39.1% 30.7% 48.5% 52.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   34.2% 21.3% 19.9% 24.7% 26.8% 29.8% 0.0% 0.0%   ROI %   50.4% 29.8% 27.2% 32.2% 32.2% 34.8% 0.0% 0.0%   ROE %   39.5% 23.4% 21.2% 24.4% 13.4% 26.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   66.7% 72.1% 71.9% 78.2% 84.8% 83.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -234.7% -427.0% -414.5% -566.0% -322.4% -357.9% 0.0% 0.0%   Gearing %   3.3% 1.8% 1.3% 1.9% 1.9% 1.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   47.7% 17.8% 29.2% 94.8% 811.9% 44.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.6 3.1 3.0 3.7 5.5 5.3 0.0 0.0   Current Ratio   3.0 3.6 3.6 4.6 6.6 6.2 0.0 0.0   Cash and cash equivalent   2,845.1 3,289.4 3,557.6 4,418.9 4,372.6 6,184.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,132.8 586.2 619.1 1,128.6 2,228.6 3,377.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   587 379 423 382 1,332 1,697 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   587 379 423 382 1,324 1,697 0 0   EBIT / employee   579 372 418 378 1,324 1,697 0 0   Net earnings / employee   442 342 374 526 677 1,647 0 0